Suspended
The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients
0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested
Oral Vitamin C
Drug
Who is being recruted
HIV Infections
Over 18 Years
See all eligibility criteria
How is the trial designed
Treatment Study
Interventional
See protocol details
Summary
Principal SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Last updated: April 14, 2023
Sourced from a government-validated database.Claim as a partner
This is a study to evaluate the tolerance and antiviral effect of oral vitamin C in HIV-infected.
Principal SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Last updated: April 14, 2023
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
0
Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sexBiological sex of participants that are eligible to enroll.
Over 18 YearsRange of ages for which participants are eligible to join.
Healthy volunteers not allowedIf individuals who are healthy and do not have the condition being studied can participate.
Conditions
Pathology
HIV Infections
Criteria
Ensure optimum compatibilityAdd your profile to know your probability eligibility score.
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.SuspendedNo study centers